Pictet Asset Management (Switzerland)’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$40.9M Buy
170,468
+60,178
+55% +$12.5M 0.05% 324
2023
Q1
$20.7M Buy
110,290
+77,734
+239% +$16.1M 0.03% 453
2022
Q4
$6.92M Buy
32,556
+8,535
+36% +$1.71M 0.01% 673
2022
Q3
$3.77M Buy
24,021
+13,513
+129% +$2.16M 0.01% 795
2022
Q2
$1.57M Buy
10,508
+8,666
+470% +$1.25M ﹤0.01% 980
2022
Q1
$301K Hold
1,842
﹤0.01% 1365
2021
Q4
$401K Sell
1,842
-58
-3% -$12.1K ﹤0.01% 1273
2021
Q3
$360K Buy
+1,900
New +$347K ﹤0.01% 1333

Other funds holding MEDP

Pictet Asset Management (Switzerland)'s MEDP Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Medpace (MEDP) stake by 55% in Q2 2023, buying an estimated $12.5M and bringing the position to 170,468 shares worth $40.9M. The position accounts for 0.05% of the portfolio, ranked #324.

Pictet Asset Management (Switzerland) first reported a position in MEDP in Q3 2021 and has held it in 8 quarters since. 464 funds tracked by Wall St. Rank hold MEDP as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 170,468 shares of Medpace worth $40.9M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 60,178 Medpace shares in Q2 2023, an estimated $12.5M.
  • Medpace made up 0.05% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #324 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Medpace in Q3 2021 and has held it in 8 quarters since.
  • 464 funds tracked by Wall St. Rank held Medpace as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.